Navigation Links
Talyst Announces AutoSplit Contract Pharmacy at 340B Coalition
Date:6/29/2012

KIRKLAND, Wash., June 29, 2012 /PRNewswire/ -- Talyst, a leader in pharmacy automation, announces AutoSplit® Contract Pharmacy at the 16th  Annual 340B Coalition. The conference highlights will include sessions devoted to program integrity and audits, key considerations when developing contract pharmacy relationships, how the 340B program helps improve and expand patient care, and practical steps and policy solutions to address drug shortages.

AutoSplit Contract Pharmacy allows health systems to capture additional 340B savings from hospital scripts dispensed at retail pharmacies. The solution is an end-to-end managed service that gives covered entities the opportunity to capture increased 340B savings.

"Disproportionate Share Hospitals (DSH) can benefit from a 340B program," said Carla Corkern, Chief Executive Officer at Talyst. "Through their additional savings from Contract Pharmacy, the DSH can provide better and safer care to their patients."

Talyst will be exhibiting at the Coalition in booth #33. For more information on the conference, visit http://www.340bcoalition.org/conferences/2012_annual/index.cfm.

About Talyst

Talyst is a leader in pharmacy automation and engineers the safer pharmacy. Our solutions provide enterprise-wide medication management across your entire health system to offer greater inventory control, enhanced workflow efficiency, and improved patient safety. As of 2012, Talyst has installed automated systems in more than 600 integrated healthcare systems, acute-care hospitals, long-term care facilities, and correctional institutions. We offer a powerful software platform with a suite of hardware components to meet your specific needs. Follow us on Twitter @Talyst_Inc or visit us at, www.talyst.com.


'/>"/>
SOURCE Talyst
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Talyst Announces New Automated Medication Packager
2. KALO Announces Distribution Areas
3. Lexicon Announces Publication of Results of Two Studies of LX4211 in Patients with Type 2 Diabetes in the Journal Clinical Pharmacology & Therapeutics
4. Medivir Announces an Interferon-Free Phase II Combination Trial With TMC435 and daclatasvir to Commence Shortly
5. Hanger, Inc. Announces Second Quarter 2012 Earnings Release Conference Call
6. ResMed Announces Conference Call And Webcast To Discuss Fourth Quarter And Fiscal Year-End 2012 Results
7. Marshall Edwards Announces Name Change to MEI Pharma ("MEIP")
8. Access Pharmaceuticals Announces Positive Data From MuGard Phase 4 Clinical Trial In Oral Mucositis At MASCC/ISOO 2012 Symposium
9. Practice Fusion Announces $34 Million in Financing Led by Artis Ventures
10. BioDelivery Sciences Announces Positive Results from BEMA Buprenorphine/Naloxone (BNX) Pharmacokinetic Study
11. Detroit Metro Convention & Visitors Bureau announces launch of Medical Meetings Initiative; recruits top leaders to Advisory Council
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... WOONSOCKET, R.I. , Dec. 2, 2016 ... hold its annual Analyst Day in New York City on Thursday, December ... the CVS Health leadership team will provide an in-depth ... and enhance shareholder value. The company will also discuss ... audio and video webcast of the event will be ...
(Date:12/2/2016)... 2, 2016 Orthopedic Implants (Including Spinal ... Expected to Gain a Significant Market Share Owing to a ... ... According to a new report by ... Sterile Packaging: Clamshell Product Type Segment Projected to Witness a ...
(Date:12/2/2016)... N.J. , Dec. 2, 2016   CytoSorbents ... immunotherapy leader commercializing its European Union approved CytoSorb ... and cardiac surgery patients worldwide, announced that Dr. ... the 9th Annual LD Micro Main Event ... , 2016 at the Luxe Sunset Boulevard Hotel in ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... , ... Mediaplanet is proud to announce the launch of ... treatments, therapeutic technologies, and revolutionized nutrition that are helping patients and physicians manage ... in the last 3 decades,” says Dr. Valentine Fuster, a world-renowned cardiologist. “This ...
(Date:12/2/2016)... ... , ... Rijuven Corp launches rejiva ( http://www.rejiva.com ), a unique wearable technology ... health technology on the market can deliver all that rejiva can. , “Rejiva promotes ... their health than the usual heart rate and steps taken”, adds Evens Augustin, CEO ...
(Date:12/2/2016)... ... December 02, 2016 , ... Today ... intelligent, connected applications, was named the best Sales Team of 2016 as part ... was made today by the Software & Information Industry Association (SIIA), the principal ...
(Date:11/30/2016)... ... , ... "I hate when the mixture of saliva and toothpaste runs down ... from Bridgewater, N.J. "I thought that there had to be a way to prevent ... patent-pending DEFLECTOR to prevent saliva and toothpaste from running down the brush handle onto ...
(Date:11/30/2016)... U.K. (PRWEB) , ... November 30, 2016 , ... ... address the tech functions and stylish design wanted by today’s consumers at an ... Cronovo Co-Founder Darin Philip says the new watch is “a game changer” when ...
Breaking Medicine News(10 mins):